Menu

Agenda*

Thursday, May 16

3:00 pm – 6:00 pm AONN+ Certification Exams

Friday, May 17

8:00 am – 11:00 am Preconference Session: The Art and Science of Grant Writing: How to Get Funds for Your Programs**

Read Overview

Preconference Session: The Art and Science of Grant Writing: How to Get Funds for Your Programs

Description:

This preconference session will be team taught by Linda Burhansstipanov, Linda Krebs and Lisa Harjo, all of whom have collaborated successfully on grant funding to support patient navigation interventions and programs since 1994.

Objectives
  1. Identify potential sources for grant funding from foundations and states
  2. Examine and critique common sections included with grant applications
  3. Identify common grant application budget mistakes and solutions
  4. Identify logical steps and tasks prior to submitting a grant
Preconference Session: Financial Navigation**

Read Overview

Preconference Session: Financial Navigation

Description:

This session will provide an overview of financial navigation.

Objectives
  1. Review the importance of financial navigation within a cancer program. Learn how to show the worth of your current program or obtain administrative buy-in for starting a new program
  2. Evaluate pre-emptive screening for financial toxicity, and encourage community support for those dealing with financial toxicity
  3. Build a foundation for your financial navigation program using framework and guidelines from national experts
  4. Evaluate tools and resources for building or enhancing your financial navigation program, including new financial navigation tools
  5. Measure and track your financial navigation program
12:00 pm – 1:30 pm

Welcome to AONN+ Midyear Conference
AONN+ Lunch

1:30 pm – 2:30 pm General Session 1: Late Effects of Immunotherapy

Read Overview

General Session 1: Late Effects of Immunotherapy

Description:

This session will focus on the identification and management of both the short-term and delayed immune-related adverse effects of immunotherapy with emphasis on NCCN guidelines and techniques needed to better advocate for patients.

Objectives
  1. Recognize immune-related adverse events of immunotherapy
  2. Gain an understanding of delayed onset of adverse events and the time frame in which said events can occur
  3. Improve their knowledge of management of side effects related to treatment and gain insight into how to better educate patients on signs and symptoms of concern
  4.  Discuss NCCN guidelines related to administration  of immunotherapy
2:30 pm – 3:30 pm General Session 2: Mental Health Across the Cancer Care Continuum

Read Overview

General Session 2: Mental Health Across the Cancer Care Continuum

Description:

This session will provide an overview of the challenges patients and their families experience while going through cancer treatment. It will offer strategies and resources for navigating cancer patients living with mental health issues.

Objectives
  1. Explain what trauma is and the importance of trauma-informed care
  2. Learn about the biopsychosocial spectrum of treating mental illness and gain insight to and understanding of the impact of mental illness on the cancer patient and their family
  3. Identify strategies and resources to empower their patients to remove barriers to their care
3:30 pm – 5:30 pm

Network with Exhibitors

Saturday, May 18

9:00 am – 10:00 am General Session 3: Unlocking Navigation Acuity

Read Overview

General Session 3: Unlocking Navigation Acuity

Description:

Tools that help to characterize patient acuity have been used in healthcare for decades and have proven successful as a means of determining staffing needs, improving patient care, and controlling costs. In collaboration with Astellas, AONN+ has embarked on the development of an oncology navigation-specific acuity tool. At a minimum, the tool will be able to be utilized in multiple settings, by different types of navigators across the continuum of the patient’s cancer journey. This project team has examined the known navigation acuity scales found in the literature to provide the basic framework for the development of a standardized acuity measurement incorporating navigation core competencies, national oncology standards, and the AONN+ navigation metrics. The session will discuss the background in developing a navigation-specific acuity tool, the operability of the tool, and plans for implementation.

Objectives
  1. Define the difference between navigation acuity and productivity
  2. State how acuity is measured across programs and settings
  3. Discuss the background, development, methodology, and future of the AONN+ Acuity Tool
10:00 am – 11:00 am General Session 4: Precision Medicine for Navigators

Read Overview

General Session 4: Precision Medicine for Navigators

Description:

This session will describe current and emerging technologies in precision medicine as applied to cancer prevention, treatment, and management. Basic genetic concepts, pertinent to oncology nurse and patient navigators, will be reviewed. Case examples and clinical trials will be discussed to best illustrate the role of navigation specific to precision medicine in oncology.

Objectives
  1. Identify basic concepts and principles in precision medicine in oncology, specific to the navigator role
  2. Identify at least 2 current precision medicine interventions used within the cancer care continuum
  3. Describe at least 1 emerging technology in the research pipeline that may soon affect cancer treatment or management
11:00 am – 12:30 pm

Network with Exhibitors

12:30 pm – 1:45 pm AONN+ Lunch
Ninlaro Presented by Takeda
2:00 pm – 3:00 pm General Session 5: Understanding Palliative Care

Read Overview

General Session 5: Understanding Palliative Care

Description:

This session will describe concepts in palliative care. The roles of the multidisciplinary team members, including oncology nurse and patient navigators, will be outlined, as they each contribute to quality of life care. Referral criteria will be reviewed, so that navigators can best facilitate proper and prompt care transitions.

Objectives
  1. Identify basic concepts and principles in palliative care, specific to the navigator role
  2. Describe the multidisciplinary team in the palliative care service, and how each of their roles contribute to quality of life care
  3. Identify at least 3 basic criteria on when to properly refer patients and their families to palliative care
3:00 pm – 4:00 pm General Session 6: Improving Access to Clinical Trials for the Adolescent and Young Adult (AYA) Cancer Patient

Read Overview

General Session 6: Improving Access to Clinical Trials for the
Adolescent and Young Adult (AYA) Cancer Patient

Description:

This session will identify barriers and facilitators to enrollment of adolescent and young adult (AYA) cancer patients into therapeutic and supportive care clinical trials in adult and pediatric settings. It will describe targeted interventions to increase access to clinical trials for the AYA patient. It will identify the role of the clinical/patient navigator in assisting the AYA patient with access to clinical trials through case studies.

Objectives
  1. Discuss the history of AYA clinical trial enrollment
  2. Recognize barriers to clinical trial enrollment of the AYA patient
  3. Discuss the disparities of AYA clinical trial enrollment at adult and pediatric facilities
  4. Identify resources and strategies to increase clinical trial enrollment for the AYA patient
4:00 pm – 5:30 pm

Network with Exhibitors

Sunday, May 19

9:00 pm – 10:00 am General Session 7: Cancer Legal Issues

Read Overview

9:00 am – 10:00 am Breakout 1: What’s Hot in Hematologic Cancers

Read Overview

Breakout 1: What’s Hot in Hematologic Cancers

Description:

This session will provide an overview of the changing landscape of hematologic cancers. It will discuss the evolution of new therapies being utilized in this population as well as the challenges these newer therapies provide for navigators.

Objectives
  1. Discuss the changing landscape of hematologic cancers
  2. Identify resources to help in the management of hematologic patients throughout the treatment trajectory
  3. Discuss the evolution of newer therapies in the treatment of these diseases
  4. Discuss the long-term toxicities of cancer treatment and the impact on the patient’s quality of life
Breakout 2: Understanding Primary Prevention

Read Overview

Breakout 2: Understanding Primary Prevention

Description:

This session will identify the current treatment and management of neuroendocrine and colorectal cancers across the cancer continuum. It will describe the key role of patient/clinical navigators in assisting patients to the proper treatment modalities and identifying barriers to care. Resources specific to this disease population will be discussed.

Objectives
  1. Describe who should receive the HPV vaccine
  2. List the cancers the HPV vaccine is used to prevent
  3. Understand the significance of clinical recommendation in increasing HPV vaccination
  4. Discuss specific steps navigators can take to increase HPV vaccination in their community
  5. Outline how HPV vaccination speaks to the values of the Triple Aim
10:00 am – 11:00 am General Session 8: Sexuality and Cancer

Read Overview

General Session 8: Sexuality and Cancer

Description:

This presentation is designed to formulate a multifaceted patient-centered approach to sexuality issues that patients and caregivers face throughout the continuum of active treatment and into survivorship.

Objectives
  1. Demonstrate an understanding of the comprehensive overview of sexuality and sexual self-image throughout the trajectory of the patient/caregiver experience
  2. Summarize the exploration of issues related to sexual side-effects of treatment and effective methodology for assessment and intervention
  3. Identify the provision of therapeutic strategies for the clinician to employ in the care of patients experiencing sexual and body-image dysfunction
  4. Implement this knowledge into the formulation of a successful therapeutic dialogue and outcome for the patient and caregiver
11:15 am – 12:15 pm Breakout 1: Improving Collaboration and Communication Among Disciplines

Read Overview

Breakout 1: Improving Collaboration and Communication Among Disciplines

Description:

Successful navigators and leaders must be able to collaborate and communicate among disciplines. Learn how role delineation, scope of practice, and mutual team work influence navigators in providing effective patient care.

Objectives
  1. Describe the importance of role delineation
  2. Discuss scope of practice
  3. Describe the importance of collaborative relationships
  4. Identify effective team-building strategies to enhance communication and patient care
Breakout 2: Understanding Neuroendocrine and Colorectal Cancers

Read Overview

Breakout 2: Understanding Neuroendocrine and Colorectal Cancers

Description:

This session will identify the current treatment and management of neuroendocrine and colorectal cancers across the cancer continuum. It will describe the key role of patient/clinical navigators in assisting patients to the proper treatment modalities and identifying barriers to care. Resources specific to this disease population will be discussed.

Objectives
  1. Discuss the role of the clinical/patient navigator in supporting patients throughout the cancer trajectory
  2. Identify current and emerging treatments for neuroendocrine and colorectal cancers, including targeted therapies and clinical trials
  3. List resources specific to this patient population
  4. Describe barriers that the clinical/patient navigator has in caring for this population
12:30 pm – 1:30 pm General Session 9: Truths and Myths of Nutrition in Cancer

Read Overview

General Session 9: Truths and Myths of Nutrition in Cancer

Description:

This session will offer navigators fact-based, essential information that can be utilized in patient/caregiver education and support throughout the continuum of care as well as survivorship planning. It will provide accurate guidance on fad diets and diet “folklore” as well as the use of alternative modalities such as multivitamins, supplements, and herbal remedies. Lastly, it will educate navigators in recognizing when patients need referral to an oncology-certified dietitian.

Objectives
  1. Incorporate accurate patient/caregiver nutritional education into the navigation paradigm
  2. Provide comprehensive and accurate advice on fad/alternative diets and supplement choices
  3. Identify the need for referral to an oncology-certified dietitian
1:30 pm – 2:00 pm Closing Remarks

*Agenda is subject to change.

Non-CE session.

**Additional fee to attend this session.

Thank you to our Corporate Sponsors and Alliance Partners!

  • National Alliance Partner

    National Alliance Partner

  • National Alliance Partner

    National Alliance Partner

  • National Healthcare SystemAlliance Partner

    National Healthcare System
    Alliance Partner

  • National Healthcare SystemAlliance Partner

    National Healthcare System
    Alliance Partner

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Cornerstone Corporate Sponsor

    Cornerstone Corporate Sponsor

  • Industry Relations Council Alliance Sponsor

    Industry Relations
    Council Alliance Sponsor

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations
    Council Member